Skip to content

Feasibility Study of Dialysis Clinic Semi-Autonomous Ultrasound Scanning Using the Vexev Ultrasound Imaging System for Arteriovenous Fistula Mapping Examinations. The CANSCAN Trial.

Feasibility Study of Dialysis Clinic Semi-Autonomous Ultrasound Scanning Using the Vexev Ultrasound Imaging System for Arteriovenous Fistula Mapping Examinations.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06691672
Acronym
CANSCAN
Enrollment
120
Registered
2024-11-15
Start date
2024-11-20
Completion date
2025-05-15
Last updated
2025-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Feasibility Assessment of the VxWave Device for Vascular Access Imaging

Brief summary

Study to assess the feasibility of dialysis clinic staff to perform upper limb mapping ultrasound scans using the Vexev Ultrasound Imaging System.

Interventions

DIAGNOSTIC_TESTRobotic Tomographic ultrasound imaging of the arm vasculature.

Semi-autonomous robotic tomographic ultrasound imaging of the arm vasculature for vascular access creation mapping in CKD patients.

Sponsors

USRC Kidney Research
CollaboratorNETWORK
Vexev Pty Ltd
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Referred to a study site for chronic renal replacement therapy OR referred to a study site for management of CKD. 2. Able to understand the procedures and requirements of the study and provide written informed consent and authorization for protected health information disclosure. 3. Greater than or equal to 21 years of age at the time of written informed consent.

Exclusion criteria

1. Patients' unable to load arm into scanning bed (due to upper limb medical co-morbidities/injury). 2. Patient has evidence of open or incompletely healed wounds on both arms. Patients with open or incompletely healed wounds on a single arm are not excluded - if the ipsilateral arm is not able to be scanned - contralateral arm may be scanned. 3. Any acute or chronic condition that would limit the ability of the patient to participate in the study - in the opinion of the principal investigator. 4. Previous vascular/vascular access surgery on both upper limbs. Patients with previous vascular/vascular access surgery on a single arm are not excluded- contralateral arm may be scanned. \-

Design outcomes

Primary

MeasureTime frameDescription
Vascular Access Robotic Tomographic Ultrasound (RTU) Mapping Efficacy and FeasabilityFrom enrollment to the end of viable assessment window at 90 days.The proportion of RTU vascular mapping scans performed using the VxWave Vascular Ultrasound Imaging Device that are assessed by interventionalists to provide sufficient imaging data to determine vascular access options.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026